Alphabet Prepares to Sell Life Sciences Unit Verily

Core Insights - Alphabet has been preparing to sell its life sciences unit, Verily, for two years, as stated by a company executive in court [1] - Verily is transitioning from Google's infrastructure to Google Cloud, indicating a move towards becoming an independent company [2] - This marks the first public acknowledgment from a Google executive regarding the intention to spin off Verily [3] Investment and Financials - In September 2022, Alphabet led a $1 billion investment round for Verily, aimed at supporting core initiatives in healthcare data and technology [4] - Verily has indicated plans for future investments in strategic partnerships and acquisitions [4] Strategic Shifts - In August, Verily laid off staff and scaled back its medical devices program, shifting focus towards artificial intelligence and data infrastructure [5] - Verily extended its partnership with Vanderbilt University Medical Center to enhance access to biomedical data for researchers [6]